Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garzone

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Family Physician|April 1, 1987
Pressure ulcersG C Xakellis, P Garzone
Waste Management (New York, N.Y.)|June 27, 2006
Agro-industry sugarcane residues disposal: the trends of their conversion into energy carriers in CubaW Alonso Pippo, P Garzone, G Cornacchia
Drug Intelligence & Clinical Pharmacy|September 1, 1983
Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summariesP Garzone, J Lyon, V L Yu
Drug Intelligence & Clinical Pharmacy|July 1, 1983
Third-generation and investigational cephalosporins: I. Structure-activity relationships and pharmacokinetic reviewP Garzone, J Lyon, V L Yu
Clinical Pharmacology and Therapeutics|July 1, 1981
Steady-state moxalactam kinetics: comparisons with other cephalosporinsP Garzone, J Lyon, V L Yu, et al.
Seminars in Hematology|June 13, 1998
Clinical evaluation of recombinant factor IXG White, A Shapiro, M Ragni, et al.
Seminars in Hematology|June 13, 1998
Preclinical studies of recombinant factor IXR Schaub, P Garzone, P Bouchard, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Family Physician|April 1, 1987
Pressure ulcersG C Xakellis, P Garzone
Waste Management (New York, N.Y.)|June 27, 2006
Agro-industry sugarcane residues disposal: the trends of their conversion into energy carriers in CubaW Alonso Pippo, P Garzone, G Cornacchia
Drug Intelligence & Clinical Pharmacy|September 1, 1983
Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summariesP Garzone, J Lyon, V L Yu
Drug Intelligence & Clinical Pharmacy|July 1, 1983
Third-generation and investigational cephalosporins: I. Structure-activity relationships and pharmacokinetic reviewP Garzone, J Lyon, V L Yu
Clinical Pharmacology and Therapeutics|July 1, 1981
Steady-state moxalactam kinetics: comparisons with other cephalosporinsP Garzone, J Lyon, V L Yu, et al.
Seminars in Hematology|June 13, 1998
Clinical evaluation of recombinant factor IXG White, A Shapiro, M Ragni, et al.
Seminars in Hematology|June 13, 1998
Preclinical studies of recombinant factor IXR Schaub, P Garzone, P Bouchard, et al.
Pageof 1